PD
DNA icon

Point72 (DIFC)’s Ginkgo Bioworks DNA Stock Holding History

Point72 (DIFC)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,162
Closed -$6.62K – 1686
2025
Q1 		$6.62K Sell
1,162
-5,200
-82% -$53K ﹤0.01% 1495
2024
Q4 		$62.5K Buy
6,362
+6,302
+10,503% +$54K ﹤0.01% 1089
2024
Q3 		$493 Sell
60
-1,834
-97% -$18.4K ﹤0.01% 1349
2024
Q2 		$25.3K Sell
1,894
-9,588
-84% -$286K ﹤0.01% 1197
2024
Q1 		$533K Buy
+11,482
New +$594K 0.02% 727

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 (DIFC)'s DNA Position: Q2 2025 in Review

Point72 (DIFC) sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 1,162 shares — an estimated $6.62K sold.

Point72 (DIFC) first reported a position in DNA in Q1 2024 and held it in 5 quarters. The position peaked at $533K in Q1 2024. 166 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Point72 (DIFC) reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 1,162 Ginkgo Bioworks shares in Q2 2025, an estimated $6.62K.
  • Point72 (DIFC) first reported a position in Ginkgo Bioworks in Q1 2024 and held it in 5 quarters.
  • Point72 (DIFC)'s Ginkgo Bioworks position peaked at $533K in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.